Wednesday, February 10, 2010, 12:09PM AEST - The Australian Stockmarket closes in 3 hours and 56 minutes.
To create a watchlist or portfolio of shares, Register

Chelsea Therapeutics International Ltd. (CHTP)

8:00AM AEST: 2.53 USD  Down 0.19 (6.99%)  
 MORE ON CHTP 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Chelsea Therapeutics Internatio (NCM:CHTP) Delayed quote dataEdit
Last Trade:2.53 USD
Trade Time: 8:00AM AEST
Change:Down 0.19 (6.99%)
Prev Close:2.72
Open:2.76
Bid:2.42 x 3000
Ask:2.69 x 5000
1y Target Est:6.67
Day's Range:2.47 - 2.79
52wk Range:1.27 - 7.51
Volume:690,563
Avg Vol (3m):389,400
Market Cap:84.76M
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add CHTP to Portfolio   Download Data

 HEADLINES 
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib
EDGAR Online (Wed 5:29AM)
InPlay: Chelsea Therapeutics announces several updates related to its Phase III registration program in neurogenic orthostatic hypotension
Briefing.com (Tue 11:33PM)
Chelsea Therapeutics Announces Advancements in Neurogenic Orthostatic Hypotension Registration Program
GlobeNewswire (Tue 11:30PM)
How the Brokers Stack Up
at Barrons.com (Sat, Feb 6)
Chelsea Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
GlobeNewswire (Wed, Feb 3)
[video] Trading Smallcap Biotech
at TheStreet.com (Tue, Feb 2)
Insider Sells $8.3M Worth of Complete Production Svs
TheStreet.com (Fri, Jan 22)
GenVec, Allied Defense: Early Volume Plays
at TheStreet.com (Tue, Jan 19)
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib
EDGAR Online (Thu, Dec 17)
StockPreacher Initiates Independent Research Coverage for Chelsea Therapeutics International Inc.
GlobeNewswire (Wed, Dec 16)
More Headlines for CHTP...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.90
EPS Est (in 2 years) (Dec-10) :-1.02
Avg Rec (current)*:1.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices